Literature DB >> 26648650

Naltrexone and liver disease.

Mike McDonough1.   

Abstract

Entities:  

Year:  2015        PMID： 26648650      PMCID： PMC4657311          DOI： 10.18773/austprescr.2015.063

Source DB:  PubMed          Journal:  Aust Prescr        ISSN： 0312-8008


× No keyword cloud information.
  5 in total

1.  Study of hepatotoxicity of naltrexone in the treatment of alcoholism.

Authors:  Mao-Hsiung Yen; Huei-Chen Ko; Fu-In Tang; Ru-Band Lu; Jau-Shyong Hong
Journal:  Alcohol       Date:  2006-02       Impact factor: 2.405

2.  Naltrexone versus acamprosate in the treatment of alcohol dependence: A multi-centre, randomized, double-blind, placebo-controlled trial.

Authors:  Kirsten C Morley; Maree Teesson; Sophie C Reid; Claudia Sannibale; Clare Thomson; Nghi Phung; Martin Weltman; James R Bell; Kylie Richardson; Paul S Haber
Journal:  Addiction       Date:  2006-10       Impact factor: 6.526

3.  The safety profile of naltrexone in the treatment of alcoholism. Results from a multicenter usage study. The Naltrexone Usage Study Group.

Authors:  R S Croop; E B Faulkner; D F Labriola
Journal:  Arch Gen Psychiatry       Date:  1997-12

4.  Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial.

Authors:  Raymond F Anton; Stephanie S O'Malley; Domenic A Ciraulo; Ron A Cisler; David Couper; Dennis M Donovan; David R Gastfriend; James D Hosking; Bankole A Johnson; Joseph S LoCastro; Richard Longabaugh; Barbara J Mason; Margaret E Mattson; William R Miller; Helen M Pettinati; Carrie L Randall; Robert Swift; Roger D Weiss; Lauren D Williams; Allen Zweben
Journal:  JAMA       Date:  2006-05-03       Impact factor: 56.272

5.  A randomized, double-blind, placebo-controlled pilot study of naltrexone in outpatients with bipolar disorder and alcohol dependence.

Authors:  E Sherwood Brown; Thomas J Carmody; Joy M Schmitz; Raul Caetano; Bryon Adinoff; Alan C Swann; A John Rush
Journal:  Alcohol Clin Exp Res       Date:  2009-08-10       Impact factor: 3.455
  5 in total
  4 in total

1.  Current Management of Alcohol-Associated Liver Disease.

Authors:  Faisal A Siddiqi; Krishna C Sajja; Nyan L Latt
Journal:  Gastroenterol Hepatol (N Y)       Date:  2020-11

2.  Medication Treatment of Active Opioid Use Disorder in Veterans With Cirrhosis.

Authors:  Shari Rogal; Ada Youk; Olufunso Agbalajobi; Hongwei Zhang; Walid Gellad; Michael J Fine; Pamela Belperio; Timothy Morgan; Chester B Good; Kevin Kraemer
Journal:  Am J Gastroenterol       Date:  2021-07-01       Impact factor: 12.045

3.  Serious adverse events reported in placebo randomised controlled trials of oral naltrexone: a systematic review and meta-analysis.

Authors:  Monica Bolton; Alex Hodkinson; Shivani Boda; Alan Mould; Maria Panagioti; Sarah Rhodes; Lisa Riste; Harm van Marwijk
Journal:  BMC Med       Date:  2019-01-15       Impact factor: 8.775

Review 4.  Novel Agents for the Pharmacological Treatment of Alcohol Use Disorder.

Authors:  Elizabeth M Burnette; Steven J Nieto; Erica N Grodin; Lindsay R Meredith; Brian Hurley; Karen Miotto; Artha J Gillis; Lara A Ray
Journal:  Drugs       Date:  2022-02-08       Impact factor: 9.546
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.